Picture of blood cells

Open Access research which pushes advances in bionanotechnology

Strathprints makes available scholarly Open Access content by researchers in the Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS) , based within the Faculty of Science.

SIPBS is a major research centre in Scotland focusing on 'new medicines', 'better medicines' and 'better use of medicines'. This includes the exploration of nanoparticles and nanomedicines within the wider research agenda of bionanotechnology, in which the tools of nanotechnology are applied to solve biological problems. At SIPBS multidisciplinary approaches are also pursued to improve bioscience understanding of novel therapeutic targets with the aim of developing therapeutic interventions and the investigation, development and manufacture of drug substances and products.

Explore the Open Access research of SIPBS. Or explore all of Strathclyde's Open Access research...

The basic reproduction number and the vaccination coverage required to eliminate Rubella from England and Wales

Sfikas, N. and Greenhalgh, D. and Lewis, F. (2007) The basic reproduction number and the vaccination coverage required to eliminate Rubella from England and Wales. Mathematical Population Studies, 14 (1). pp. 3-29. ISSN 0889-8480

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

Bootstrapping is used to estimate the effectiveness of different vaccination strategies for rubella in England and Wales. It is assumed that rubella infection follows the deterministic age-structured model discussed by Dietz and Schenzle (1985). The bootstrap is used to estimate percentile confidence intervals for the basic reproductive number and the minimum elimination proportions under one and two stage vaccination campaigns for rubella. The results of differing mixing assumptions and the effects of kernel smoothing are also considered. Previous estimates of the basic reproduction number and minimum elimination vaccination proportions for rubella and similar diseases are discussed and the results compared with those of the article. For homogeneous mixing only, the estimates are much lower than previous estimates. For more realistic symmetric mixing a worse 'reasonable' vaccination coverage estimate of around 87% of children as young as possible is needed to eliminate rubella in England and Wales.